Clinical Trial Update: A Study to Assess Adverse Events and Change in Disease Condition of Mesalamine Capsules in Children Aged 5 to 17 Years With Ulcerative Colitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of mesalamine capsules in children aged 5 to 17 with ulcerative colitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mesalamine Capsules (mesalamine)

Snippet

Sponsor: AbbVie | Conditions: Ulcerative Colitis (UC) | Phase 3 | Status: WITHDRAWN